[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100452975":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":45,"centralContacts":49,"locations":55,"responsibleParty":75,"collaborators":10,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":10,"eligibilityCriteria":84,"healthyVolunteers":80,"sex":85,"minAge":86,"maxAge":10,"enrollmentInfo":87,"targetDuration":10,"studyType":90,"phases":10,"briefSummary":91,"conditions":92,"keywords":10,"overallStatus":57,"whyStopped":10,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Ohio State University Comprehensive Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational (physical exam, questionnaire)",null,"Patients complete physical measurements every 6 months and complete questionnaires annually for 5 years. Patients are followed up annually in years 5-10.",[13,14,15],"Procedure: Follow-Up","Procedure: Physical Examination","Other: Questionnaire Administration",[17,30,41],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"PROCEDURE","Follow-Up","Undergo follow up",[9],[23,24,25,26,27,28,29],"Active Follow-up","Clinical Signs Follow-up","CLSFUP","Follow Up","follow_up","Followed","Followup",{"type":18,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"Physical Examination","Complete physical measurements",[9],[35,36,37,38,39,40],"Assessment","General Examination","Physical","Physical Assessment","Physical Exam","physical_exam",{"type":6,"name":42,"description":43,"armGroupLabels":44,"otherNames":10},"Questionnaire Administration","Complete questionnaires",[9],[46],{"name":47,"affiliation":5,"role":48},"Sagar D Sardesai, MSPH, PhD","PRINCIPAL_INVESTIGATOR",[50],{"name":51,"role":52,"phone":53,"phoneExt":10,"email":54},"The Ohio State University Comprehensive Cancer Center","CONTACT","800-293-5066","OSUCCCClinicaltrials@osumc.edu",[56],{"facility":5,"status":57,"city":58,"state":59,"zip":60,"country":61,"countryCode":62,"cosmosGeoPoint":63,"geoPoint":68,"contacts":69},"RECRUITING","Columbus","Ohio","43210","United States","US",{"type":64,"coordinates":65},"Point",[66,67],-82.99879,39.96118,{"lat":67,"lon":66},[70,74],{"name":71,"role":52,"phone":72,"phoneExt":10,"email":73},"Sagar D. Sardesai, MSPH, PhD","614-293-6401","Sagar.Sardesai@osumc.edu",{"name":71,"role":48,"phone":10,"phoneExt":10,"email":10},{"type":48,"investigatorFullName":76,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Sagar Sardesai","Principal Investigator","100452975","impact-of-dietary-inflammatory-potential-on-breast-cancer-risk-100452975",false,"NCT05178498","Impact of Dietary Inflammatory Potential on Breast Cancer Risk","Longitudinal Study Evaluating the Impact of Dietary Inflammatory Potential on Breast Cancer Risk in a Cohort of Women Followed in the Breast Cancer Prevention Clinic at the Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute","Inclusion Criteria:\n\n* Age \\>= 18 years\n* Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer \\[BC\\], known genetic predisposition, personal history of known atypia\u002Fbreast lobular carcinoma in situ \\[LCIS\\], or prior chest wall radiation)\n* Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)\n* Able to read and understand English\n* Able to provide informed consent\n* Must consent to continued follow-up of medical records during the study period\n\nExclusion Criteria:\n\n* Prisoners\n* Not able to speak and understand English\n* Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC","ALL","18 Years",{"count":88,"type":89},960,"ESTIMATED","OBSERVATIONAL","This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.",[93,94,95,96,97],"Breast Atypical Ductal Hyperplasia","Breast Atypical Lobular Hyperplasia","Breast Carcinoma","Breast Lobular Carcinoma In Situ","Breast Sclerosing Adenosis","2026-06-10",{"date":100,"type":101},"2026-06-12","ACTUAL",{"date":103,"type":101},"2023-10-25",{"date":105,"type":89},"2035-12-31",{"name":5,"class":6},1]